More Questions We've Answered Related to This Product
We’ve provided several answers to questions related to Saphris (Asenapine) , see some other helpful Q&A related to this product.
-
Question: What are the recommended dosages for bipolar I disorder in pediatric patients?
Answer: The recommended dosages for bipolar I disorder in pediatric patients aged 10 to 17 years range from 2.5 mg sublingually twice a day to 10 mg sublingually twice a day. Adjusting dosages for children ensures safe and effective treatment.
-
Question: What are the potential risks of taking this medication while pregnant?
Answer: Taking this medication during pregnancy may increase the risk of extrapyramidal symptoms and withdrawal symptoms in newborns. It's essential to weigh the benefits against risks and consult a healthcare provider for guidance.
-
Question: How is the medication administered?
Answer: The medication is administered sublingually or by mouth. Sublingual administration can provide faster absorption and onset of action compared to swallowing the tablet.
-
Question: What is the formula for the active ingredient in the medication?
Answer: The formula for asenapine, the active ingredient, is C17H16ClNO. Understanding the chemical formula can be valuable for those who are interested in the chemical composition and properties of the medication.
